Literature DB >> 24030550

Carotid atherosclerosis and incident atrial fibrillation.

Karin Willeit1, Raimund Pechlaner, Georg Egger, Siegfried Weger, Martin Oberhollenzer, Johann Willeit, Stefan Kiechl.   

Abstract

OBJECTIVE: Atrial fibrillation (AF) and atherosclerotic vascular disease are closely entangled disorders and often coexist. Whether atherosclerosis predisposes to the development of AF has not been fully elucidated. APPROACH AND
RESULTS: This study was performed within the framework of the Bruneck Study, a population-based survey with near-complete participation (932 of 1000), long-term follow-up (1990-2010), and thorough assessment of AF. The carotid arteries served as a window to systemic atherosclerosis and were scanned every 5 years. Pooled logistic regression and multistate proportional hazards models were used to identify risk predictors of incident AF and effects of AF on mortality. During follow-up, 118 new cases of AF were detected (incidence per 1000 person-years of 8.1; 95% confidence interval, 6.8-9.6). Individuals with atherosclerosis were more likely to develop AF than individuals without (odds ratio, 1.8; 95% confidence interval, 1.1-3.1; P=0.021). This finding applied to women and men and to both baseline and incident atherosclerosis during follow-up. Subjects with atherosclerosis and AF were significantly more likely to die than those with either condition alone (P=0.0034), and mortality in this group was ≈ 4-fold compared with individuals free of atherosclerosis and AF (hazard ratio, 4.2; 95% confidence interval, 2.6-6.8; P<0.0001).
CONCLUSIONS: We found that subjects with carotid atherosclerosis are at high risk of developing AF.

Entities:  

Keywords:  atherosclerosis; atrial fibrillation; epidemiology; population; prognosis

Mesh:

Year:  2013        PMID: 24030550     DOI: 10.1161/ATVBAHA.113.302272

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  Left Ventricular Systolic Dysfunction by Longitudinal Strain Is an Independent Predictor of Incident Atrial Fibrillation: A Community-Based Cohort Study.

Authors:  Cesare Russo; Zhezhen Jin; Fusako Sera; Edward S Lee; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

2.  Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Authors:  Shingo Kato; Murilo Foppa; Sébastien Roujol; Tamer Basha; Sophie Berg; Kraig V Kissinger; Beth Goddu; Warren J Manning; Reza Nezafat
Journal:  Int J Cardiol       Date:  2015-11-11       Impact factor: 4.164

Review 3.  Carotid Atherosclerosis in Patients with Atrial Fibrillation.

Authors:  Zhaojia Wang; Panagiotis Korantzopoulos; Tong Liu
Journal:  Curr Atheroscler Rep       Date:  2019-11-29       Impact factor: 5.113

4.  Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.

Authors:  Karin Willeit; Raimund Pechlaner; Peter Willeit; Philipp Skroblin; Bernhard Paulweber; Christiana Schernthaner; Thomas Toell; Georg Egger; Siegfried Weger; Martin Oberhollenzer; Ludmilla Kedenko; Bernhard Iglseder; Enzo Bonora; Georg Schett; Manuel Mayr; Johann Willeit; Stefan Kiechl
Journal:  JAMA Cardiol       Date:  2017-05-01       Impact factor: 14.676

5.  Association of homocysteine with carotid atherosclerosis in hypertension.

Authors:  Ai Chen; Weibin Wu; Jin Gong; Ying Han; Guoyan Xu; Liangdi Xie
Journal:  J Hum Hypertens       Date:  2022-03-11       Impact factor: 2.877

Review 6.  Looking into a conceptual framework of ROS-miRNA-atrial fibrillation.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ki-Chul Hwang
Journal:  Int J Mol Sci       Date:  2014-11-26       Impact factor: 5.923

7.  Relationship of the total atrial conduction time to subclinical atherosclerosis, inflammation and echocardiographic parameters in patients with type 2 diabetes mellitus.

Authors:  Eftal Murat Bakirci; Levent Demirtas; Husnu Degirmenci; Selim Topcu; Selami Demirelli; Hikmet Hamur; Mutlu Buyuklu; Emin Murat Akbas; Adalet Ozcicek; Fatih Ozcicek; Gokhan Ceyhun; Ergun Topal
Journal:  Clinics (Sao Paulo)       Date:  2015-02       Impact factor: 2.365

8.  Role of the CHADS2 Score in the Evaluation of Carotid Atherosclerosis in Patients with Atrial Fibrillation Undergoing Carotid Artery Ultrasonography.

Authors:  Le-Yu Lin; Lian-Wei Yang; Yuan-Yuan Shang; Yi-Hui Li; Ming Zhong; Wei Zhang; Hui Zhu
Journal:  Biomed Res Int       Date:  2018-08-19       Impact factor: 3.411

9.  Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol.

Authors:  Thomas Toell; Christian Boehme; Lukas Mayer; Stefan Krebs; Clemens Lang; Karin Willeit; Barbara Prantl; Michael Knoflach; Gerhard Rumpold; Gudrun Schoenherr; Andrea Griesmacher; Peter Willeit; Julia Ferrari; Wilfried Lang; Stefan Kiechl; Johann Willeit
Journal:  BMC Neurol       Date:  2018-11-06       Impact factor: 2.474

10.  Subclinical Measures of Peripheral Atherosclerosis and the Risk of New-Onset Atrial Fibrillation in the General Population: the Rotterdam Study.

Authors:  Sven Geurts; Cathrine Brunborg; Grigorios Papageorgiou; M Arfan Ikram; Maryam Kavousi
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.